RT Journal Article
SR Electronic
T1 Point-of-care thermal imaging tool assisting in the development of imaging biomarker as pre-diagnostics of graves’ disease
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.07.05.22277045
DO 10.1101/2022.07.05.22277045
A1 Vaishali Sharma
A1 Vandana K Dhingra
A1 Ashok Kumar
A1 Snehlata Shakya
A1 Mayank Goswami
YR 2022
UL http://medrxiv.org/content/early/2022/07/07/2022.07.05.22277045.abstract
AB This article presents the development of a tool to address the scarcity of clinically validated datasets for Thyroid related abnormalities. Infrared thermography Images are taken from each of the sixty persons of different age groups and gender. Scintigraphy and standard thyroid blood test results are used to categorize these persons into thirty-three females and thirteen males suffering from graves’ disease. Eleven females and three males are found to be in healthy conditions and used as control. An Artificial Intelligence algorithm is used to automatically segment and extract the histogram-associated information within the thyroid and cheek region from the collected images. A very simple and novel imaging biomarker is found to be moderately correlated w.r.t age and gender. A smartphone app integrated with a dedicated smartphone-based compact IR camera add-on is developed and deployed in a clinical environment to enrich the analysis. This point-of-care tool is expected to categorize healthy cases from patients automatically. It is to reduce the ethical burden on clinicians’ shoulders before recommending radioactive contamination-prone Scintigraphy and/or expensive and relatively slower thyroid blood tests. If adopted, such preliminary tests will save costs on patients’ end and burden at pathology labs, especially in densely populated countries such as India.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by UCOST and AIIMS Rishikesh Intramural FundsAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the All-India Institute of Medical Science Rishikesh Ethics Committee with reference number AIIMS/IEC/19/997. Its detail can be found here: https://aiimsrishikesh.edu.in/a1_1/?page_id=1739I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.